Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bristol-Myers Squibb Co Reaffirms FY 2013 EPS Guidance


Wednesday, 23 Oct 2013 07:30am EDT 

Bristol-Myers Squibb Co confirmed its fiscal 2013 GAAP EPS guidance range of $1.41 to $1.49 and its fiscal 2013 non-GAAP EPS Guidance Range of $1.70 to $1.78. Both GAAP and non-GAAP guidance assume current exchange rates. The financial guidance for 2013 excludes the impact of any potential strategic acquisitions and divestitures, and any specified items that have not yet been identified and quantified. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $1.73 for fiscal 2013. 

Company Quote

65.0
-0.32 -0.49%
11:02am EDT